Amanote Research
Register
Sign In
New Analogs of the Complement C3 Inhibitor Compstatin With Increased Solubility and Improved Pharmacokinetic Profile
doi 10.1021/acs.jmedchem.8b00560.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Studies of Structure-Activity Relations of Complement Inhibitor Compstatin.
Journal of Immunology
Allergy
Immunology
Compstatin: A Complement Inhibitor on Its Way to Clinical Application
Advances in Experimental Medicine and Biology
Biochemistry
Medicine
Genetics
Molecular Biology
Cover Picture: Conjugation to Albumin-Binding Molecule Tags as a Strategy to Improve Both Efficacy and Pharmacokinetic Properties of the Complement Inhibitor Compstatin (ChemMedChem 10/2014)
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Complement C3 Inhibitor Cp40 Attenuates Xenoreactions in Pig Hearts Perfused With Human Blood
Xenotransplantation
Transplantation
Immunology
Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir
Clinical Pharmacokinetics
Pharmacology
Comparison of Enhanced Solubility Profile Analysis of Thermodynamic Parameters and Pharmacokinetic Profile Related to Tamoxifen Citrate Solubilisation
Novel Approaches in Drug Designing & Development
Activation of Complement (C3) in Patients With Leprosy
Leprosy Review
Dermatology
Medicine
Infectious Diseases
Toward a Molecular Understanding of Protein Solubility: Increased Negative Surface Charge Correlates With Increased Solubility
Biophysical Journal
Biophysics
Pharmacological Profile of Mephedrone Analogs and Related New Psychoactive Substances
Neuropharmacology
Molecular Neuroscience
Cellular
Pharmacology
